Myocardial viability imaging using a novel non-breath-hold cardiac MRI protocol: a comparative assessment with 18F-FDG PET

被引:2
|
作者
Aggarwal, Rohit [1 ]
Singla, Geetika [2 ]
Singh, Harkirat [3 ]
George, Raju Augustine [2 ]
Mukhopadhyay, Indrani [4 ]
机构
[1] 7 Air Force Hosp, Dept Radiol, Nathu Singh Rd,Kanpur Cantonment, Kanpur, Uttar Pradesh, India
[2] Command Hosp Air Force, Dept Radiol, Bangalore, Karnataka, India
[3] Mil Hosp Roorkee, Roorkee, Uttarakhand, India
[4] Armed Forces Med Coll, Dept Obstet & Gynaecol, Pune, Maharashtra, India
来源
关键词
Myocardial viability; Magnetic resonance imaging; Positron emission tomography; LEFT-VENTRICULAR DYSFUNCTION; CORONARY-ARTERY-DISEASE; ENHANCED MAGNETIC-RESONANCE; PROGNOSTIC VALUE; REVASCULARIZATION; IMPACT;
D O I
10.1186/s43055-020-00294-z
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background Delayed contrast enhancement on cardiac magnetic resonance imaging is a well-established MRI technique for the evaluation of myocardial tissue viability. A comprehensive cardiac MRI protocol for myocardial viability comprises of multiple breath hold sequences to provide information regarding chamber volumes, myocardial mass, and function in addition to viability. However, its routine use is limited mainly by lengthy acquisition time and patient's inability to hold breath in multiple breath hold sequences. The important question to which the referring cardiologists/cardiac surgeons are seeking answer is that "What are the viable vascular territories that will benefit from revascularization?" In this study, we have analyzed the utility of non-breath-hold rapid delayed contrast-enhanced cardiac MR imaging protocol for myocardial viability assessment with 18-flourodeoxyglucose positron emission tomography (F-18-FDG PET) as the reference standard. Results Forty patients of ischemic heart disease who met the inclusion criteria were included. All patients underwent both(18)F-FDG PET and delayed contrast-enhanced cardiac magnetic resonance imaging as per the non-breath-hold protocol. In this free-breathing protocol, the breath hold cine sequences were omitted and, after localizers, post-contrast scans were obtained with a time gap of 15 min post-contrast administration. A total number of 680 myocardial segments and corresponding 120 vascular territories were assessed. MRI and(18)F-FDG PET images were analyzed using a 17-segment model as proposed by AHA. Sensitivity, specificity, positive predictive value, and negative predictive value of non-breath-hold rapid delayed contrast-enhanced cardiac MR imaging protocol for assessing myocardial viability (on segment analysis) was 95.5%, 65.59%, 88.0%, and 84.72%, respectively, and of vascular territory analysis were 96.77%, 92.59%, 97.83%, and 89.29%, respectively, in relation to(18)F-FDG PET used as the reference standard. Spearman's rank correlation coefficient is 0.62. Conclusion This modified non-breath-hold delayed contrast-enhanced cardiac MR imaging protocol is a reliable tool to answer the clinically relevant question of myocardial viability with a significant reduction in acquisition time and overcomes the limiting need of breath hold.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Myocardial viability imaging using a novel non-breath-hold cardiac MRI protocol: a comparative assessment with 18F-FDG PET
    Rohit Aggarwal
    Geetika Singla
    Harkirat Singh
    Raju Augustine George
    Indrani Mukhopadhyay
    Egyptian Journal of Radiology and Nuclear Medicine, 51
  • [2] 18F-FDG PET in Myocardial Viability Assessment: A Practical and Time-Efficient Protocol
    Mhlanga, Joyce
    Derenoncourt, Paul
    Haq, Adeel
    Bhandiwad, Anita
    Laforest, Richard
    Siegel, Barry A.
    Dehdashti, Farrokh
    Gropler, Robert J.
    Schindler, Thomas H.
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (04) : 602 - 608
  • [3] 18F-FDG PET and Myocardial Viability Assessment: Trials and Tribulations
    Allman, Kevin C.
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (04) : 505 - 506
  • [4] Pitfalls of 18F-FDG PET for evaluating myocardial viability
    Osamu Manabe
    Noriko Oyama-Manabe
    Masanao Naya
    Tadao Aikawa
    Mamoru Sakakibara
    Hiroyuki Tsutsui
    Nagara Tamaki
    Journal of Nuclear Cardiology, 2017, 24 : 1110 - 1113
  • [5] Pitfalls of 18F-FDG PET for evaluating myocardial viability
    Manabe, Osamu
    Oyama-Manabe, Noriko
    Naya, Masanao
    Aikawa, Tadao
    Sakakibara, Mamoru
    Tsutsui, Hiroyuki
    Tamaki, Nagara
    JOURNAL OF NUCLEAR CARDIOLOGY, 2017, 24 (03) : 1110 - 1113
  • [6] 18F-FDG PET/MR myocardial infarct and viability imaging: Early experiences
    Lau, Jeffrey
    Laforest, Richard
    Zheng, Jie
    Priatna, Agus
    Lesniak, Donna
    Gropler, Robert
    Woodard, Pamela
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [7] The comparative performances of 18F-FDG PET/MRI and 18F-FDG PET/CT for the detection of pancreatic neoplasms
    Xing, H.
    Hou, B.
    Zhu, W.
    Ding, H.
    Li, X.
    Hu, Y.
    Xue, H.
    Feng, F.
    Lv, K.
    Wu, X.
    Li, F.
    Jin, Z.
    Li, D.
    Huo, L.
    Zhao, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S501 - S501
  • [8] Assessment of myocardial viability in the rat infarct model using 18F-FDG, 18F-FPBG, and MRI image
    Woo, Sang-Keun
    Shin, Un-Chol
    Kim, Kyeong Min
    Lee, Yong Jin
    Lee, Kyo Chul
    Moon, Byung Seok
    Lee, Byung Chul
    Kim, Sang Eun
    Kang, Joo Hyun
    Lim, Sang Moo
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [9] 13N-AMMONIA and 18F-FDG PET for Myocardial Viability Assessment: Definition and Validation of a Nursing Protocol
    Lopez Gandul, S.
    Perez Moure, G.
    Simo Perdigo, M.
    Garcia Garzon, J. R.
    Soler Peter, M.
    Lomena Caballero, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S288 - S288
  • [10] Imaging in myositis: MRI or 18F-FDG PET/CT?
    Ilgen, Ufuk
    Emmungil, Hakan
    CLINICAL RHEUMATOLOGY, 2022, 41 (07) : 2253 - 2254